These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 24239568)

  • 41. Specialized Pro-Resolving Lipid Mediators: New Therapeutic Approaches for Vascular Remodeling.
    Díaz Del Campo LS; Rodrigues-Díez R; Salaices M; Briones AM; García-Redondo AB
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408952
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Resolution of inflammation: An organizing principle in biology and medicine.
    Panigrahy D; Gilligan MM; Serhan CN; Kashfi K
    Pharmacol Ther; 2021 Nov; 227():107879. PubMed ID: 33915177
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Use of Specialized Pro-Resolving Mediators in Biomaterial-Based Immunomodulation.
    Sousa AB; Barbosa JN
    J Funct Biomater; 2023 Apr; 14(4):. PubMed ID: 37103313
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aspirin-triggered proresolving mediators stimulate resolution in cancer.
    Gilligan MM; Gartung A; Sulciner ML; Norris PC; Sukhatme VP; Bielenberg DR; Huang S; Kieran MW; Serhan CN; Panigrahy D
    Proc Natl Acad Sci U S A; 2019 Mar; 116(13):6292-6297. PubMed ID: 30862734
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endogenous Specialized Proresolving Mediator Profiles in a Novel Experimental Model of Lymphatic Obstruction and Intestinal Inflammation in African Green Monkeys.
    Becker F; Romero E; Goetzmann J; Hasselschwert DL; Dray B; Vanchiere J; Fontenot J; Yun JW; Norris PC; White L; Musso M; Serhan CN; Alexander JS; Gavins FNE
    Am J Pathol; 2019 Oct; 189(10):1953-1972. PubMed ID: 31547920
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Resolution of adipose tissue inflammation.
    González-Périz A; Clària J
    ScientificWorldJournal; 2010 May; 10():832-56. PubMed ID: 20454765
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impaired local production of proresolving lipid mediators in obesity and 17-HDHA as a potential treatment for obesity-associated inflammation.
    Neuhofer A; Zeyda M; Mascher D; Itariu BK; Murano I; Leitner L; Hochbrugger EE; Fraisl P; Cinti S; Serhan CN; Stulnig TM
    Diabetes; 2013 Jun; 62(6):1945-56. PubMed ID: 23349501
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [What the surgeon needs to know about basic new concepts of inflammation and their therapeutic consequences: sanitation of inflammation is not a passive but rather an active process regulated by lipid mediators].
    Gardemann A; Meyer F; Braun-Dullaeus R
    Zentralbl Chir; 2013 Jun; 138(3):322-30. PubMed ID: 23807584
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immuno-Resolving Ability of Resolvins, Protectins, and Maresins Derived from Omega-3 Fatty Acids in Metabolic Syndrome.
    Kwon Y
    Mol Nutr Food Res; 2020 Feb; 64(4):e1900824. PubMed ID: 31797565
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins.
    Spite M; Serhan CN
    Circ Res; 2010 Nov; 107(10):1170-84. PubMed ID: 21071715
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Deciphering the role of n-3 polyunsaturated fatty acid-derived lipid mediators in health and disease.
    Spite M
    Proc Nutr Soc; 2013 Nov; 72(4):441-50. PubMed ID: 23991833
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cutting Edge: Human Vagus Produces Specialized Proresolving Mediators of Inflammation with Electrical Stimulation Reducing Proinflammatory Eicosanoids.
    Serhan CN; de la Rosa X; Jouvene CC
    J Immunol; 2018 Dec; 201(11):3161-3165. PubMed ID: 30355784
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New endogenous anti-inflammatory and proresolving lipid mediators: implications for rheumatic diseases.
    Yacoubian S; Serhan CN
    Nat Clin Pract Rheumatol; 2007 Oct; 3(10):570-9; quiz 1 p following 589. PubMed ID: 17906612
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Resolvin D1 Reduces Emphysema and Chronic Inflammation.
    Hsiao HM; Thatcher TH; Colas RA; Serhan CN; Phipps RP; Sime PJ
    Am J Pathol; 2015 Dec; 185(12):3189-201. PubMed ID: 26468975
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chiral lipidomics of E-series resolvins: aspirin and the biosynthesis of novel mediators.
    Oh SF; Vickery TW; Serhan CN
    Biochim Biophys Acta; 2011 Nov; 1811(11):737-47. PubMed ID: 21712098
    [TBL] [Abstract][Full Text] [Related]  

  • 56. G-Protein Coupled Receptors Involved in the Resolution of Inflammation: Ligands and Therapeutic Perspectives.
    Mastromarino M; Lacivita E; Colabufo NA; Leopoldo M
    Mini Rev Med Chem; 2020; 20(20):2090-2103. PubMed ID: 32682373
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in Inflammation.
    Recchiuti A; Serhan CN
    Front Immunol; 2012; 3():298. PubMed ID: 23093949
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human inflammatory and resolving lipid mediator responses to resistance exercise and ibuprofen treatment.
    Markworth JF; Vella L; Lingard BS; Tull DL; Rupasinghe TW; Sinclair AJ; Maddipati KR; Cameron-Smith D
    Am J Physiol Regul Integr Comp Physiol; 2013 Dec; 305(11):R1281-96. PubMed ID: 24089379
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Docosahexaenoic Acid-Derived Fatty Acid Esters of Hydroxy Fatty Acids (FAHFAs) With Anti-inflammatory Properties.
    Kuda O; Brezinova M; Rombaldova M; Slavikova B; Posta M; Beier P; Janovska P; Veleba J; Kopecky J; Kudova E; Pelikanova T; Kopecky J
    Diabetes; 2016 Sep; 65(9):2580-90. PubMed ID: 27313314
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Resolvins and protectins in the termination program of acute inflammation.
    Ariel A; Serhan CN
    Trends Immunol; 2007 Apr; 28(4):176-83. PubMed ID: 17337246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.